Sanjeevani Ayurveda Hospital And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-11-2024
- Paid Up Capital ₹ 0.10 M
as on 01-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 98.55%
(FY 2023)
- Profit 602.38%
(FY 2023)
- Ebitda 435.29%
(FY 2023)
- Net Worth 209.22%
(FY 2023)
- Total Assets 136.99%
(FY 2023)
About Sanjeevani Ayurveda Hospital And Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunilkumar Nair and Sulochanabai Thankamma serve as directors at the Company.
- CIN/LLPIN
U85110KL2020PTC061407
- Company No.
061407
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sanjeevani Ayurveda Hospital And Research Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunilkumar Nair  | Director | 31-Jan-2020 | Current |
| Sulochanabai Thankamma | Director | 31-Jan-2020 | Current |
Financial Performance of Sanjeevani Ayurveda Hospital And Research Institute.
Sanjeevani Ayurveda Hospital And Research Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.55% increase. The company also saw a substantial improvement in profitability, with a 602.38% increase in profit. The company's net worth Soared by an impressive increase of 209.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjeevani Ayurveda Hospital And Research Institute?
Unlock access to Sanjeevani Ayurveda Hospital And Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanjeevani Ayurveda Hospital And Research Institute?
Unlock and access historical data on people associated with Sanjeevani Ayurveda Hospital And Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjeevani Ayurveda Hospital And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeevani Ayurveda Hospital And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
